ArticleMolecular cancer therapeutics2021

A Novel Nrf2 Pathway Inhibitor Sensitizes Keap1-Mutant Lung Cancer Cells to Chemotherapy.

Di Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.